Cloughesy, Timothy; Finocchiaro, Gaetano; Belda-Iniesta, Cristóbal; Recht, Lawrence; Brandes, Alba A; Pineda, Estela; Mikkelsen, Tom; Chinot, Olivier L; Balana, Carmen; Macdonald, David R; Westphal, Manfred; Hopkins, Kirsten; Weller, Michael; Bais, Carlos; Sandmann, Thomas; Bruey, Jean-Marie; Koeppen, Hartmut; Liu, Bo; Verret, Wendy; Phan, See-Chun; Shames, David S (2017). Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O(6)-Methylguanine-DNA Methyltransferase Biomarker Analyses. Journal of Clinical Oncology, 35(3):343-351.
Statistics
Citations
Dimensions.ai Metrics
8 citations in Web of Science®
11 citations in Scopus®
9 citations in Microsoft Academic
Google Scholar™
11 citations in Scopus®
9 citations in Microsoft Academic
Google Scholar™
Altmetrics
Downloads
Additional indexing
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Language: | English |
| Date: | 20 January 2017 |
| Deposited On: | 27 Oct 2017 07:09 |
| Last Modified: | 19 Feb 2018 08:58 |
| Publisher: | American Society of Clinical Oncology |
| ISSN: | 0732-183X |
| OA Status: | Green |
| Free access at: | Publisher DOI. An embargo period may apply. |
| Publisher DOI: | https://doi.org/10.1200/JCO.2015.64.7685 |
| PubMed ID: | 27918718 |
Cloughesy, Timothy